NCLH vs RPRX · P/E 16, rev $4.97B vs P/E 15, rev $1.30B
Norwegian Cruise Line Holdings Ltd (NCLH) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
NCLH currently screens at market cap $9.10B and trailing P/E 16.0. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the NCLH and RPRX stock pages for the full models.
Not investment advice.